Deenan Pillay

发表

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

Robert J. Gifford, Soo-Yon Rhee, Tommy F. Liu, 2009, Bioinform..

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients.

Li Xu, Stephen Taylor, Stéphane Hué, 2002, AIDS.

Positive and Negative drug Selection Pressures on the N348I Connection Domain Mutation: New Insights from in vivo Data

David Dunn, Huw Price, Deenan Pillay, 2010, Antiviral therapy.

The impact of structural and functional constraints acting at the nucleic acid level on the evolution of drug resistance in HIV-1

Paul Kellam, Deenan Pillay, Rjm Gifford, 2006 .

Towards an ultra-rapidsmartphone- connected test forinfectious diseases

Vincent C. Emery, Rachel A. McKendry, Robin A. Weiss, 2017 .

Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation

Andrew Phillips, Deenan Pillay, Valentina Cambiano, 2014, AIDS.

Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity

Deenan Pillay, Patricia A. Cane, C. Schiffer, 2010, Antimicrobial Agents and Chemotherapy.

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2006, Antimicrobial Agents and Chemotherapy.

Update of the drug resistance mutations in HIV-1: Fall 2006.

Deenan Pillay, Victoria A Johnson, Francoise Brun-Vezinet, 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

Samantha J Lycett, Manon Ragonnet-Cronin, Stéphane Hué, 2014, AIDS.

Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes

Astrid Gall, Paul Kellam, Matthew Cotten, 2012, Journal of Clinical Microbiology.

The HIV-1 Subtype C Epidemic in South America Is Linked to the United Kingdom

Tulio de Oliveira, Robert J. Gifford, Deenan Pillay, 2010, PloS one.

Update of the drug resistance mutations in HIV-1: Spring 2008.

Huldrych F Günthard, Deenan Pillay, Victoria A Johnson, 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.

HIV-1 Full-Genome Phylogenetics of Generalized Epidemics in Sub-Saharan Africa: Impact of Missing Nucleotide Characters in Next-Generation Sequences

Astrid Gall, Alexey M. Kozlov, Alexandros Stamatakis, 2017, AIDS research and human retroviruses.

Global epidemiology of drug resistance after failure of WHO recommended fi rst-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Huldrych F. Günthard, Tulio de Oliveira, Lynn Morris, 2019 .

Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals

David Dunn, Robert J. Gifford, Deenan Pillay, 2009, Journal of Virology.

Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections

Martin Fisher, Caroline A Sabin, Gary Murphy, 2005, AIDS.

Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study

Spiros Denaxas, Christina Pagel, Harry Hemingway, 2020, The Lancet.

Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells

Deenan Pillay, Clare Jolly, D. Pillay, 2013, Retrovirology.

Update of the Drug Resistance Mutations in HIV-1: December 2008

Deenan Pillay, Victoria A Johnson, Francoise Brun-Vezinet, 2008 .

Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women

Pat A Tookey, Caroline A Sabin, Deenan Pillay, 2012, BMC Medical Research Methodology.

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors are subtype dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2004 .

Drug resistance mutations in HIV-1.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2003, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

Deenan Pillay, D. Pillay, A. Phillips, 2008, The Lancet.

Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups.

Stéphane Hué, Deenan Pillay, Oliver G Pybus, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Edinburgh Research Explorer Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1

Anne-Mieke Vandamme, Paul Kellam, David Dunn, 2007 .

Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa

Till Bärnighausen, Deenan Pillay, Sydney Rosen, 2017, PLoS medicine.

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Sabine Yerly, Huldrych F Günthard, Deenan Pillay, 2009, The Lancet. Infectious diseases.

Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity

Anne-Mieke Vandamme, Paul Kellam, David Dunn, 2006, AIDS.

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

Deenan Pillay, Pontiano Kaleebu, Anne Kapaata, 2015, PloS one.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa

Till Bärnighausen, Sally Wyke, Sebastian Vollmer, 2018, AIDS.

Update of the drug resistance mutations in HIV-1: Fall 2005.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Anne-Mieke Vandamme, Soo-Yon Rhee, Tommy F. Liu, 2009, PloS one.

HIV phylogenetics

Andrew Rambaut, Deenan Pillay, D. Pillay, 2007, BMJ : British Medical Journal.

Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa

Justen Manasa, Richard Lessells, Siva Danaviah, 2016, AIDS research and human retroviruses.

2015 Update of the Drug Resistance Mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2015, Topics in antiviral medicine.

Digital technologies in the public-health response to COVID-19

Ingemar J. Cox, Geraint Rees, Vincent C. Emery, 2020, Nature Medicine.

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2005, PLoS medicine.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

David Dunn, Kholoud Porter, Rodolphe Thiébaut, 2011, The Lancet. Infectious diseases.

Effective immunity and second waves: a dynamic causal modelling study.

Adeel Razi, Karl J. Friston, Guillaume Flandin, 2020, Wellcome open research.

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Tulio de Oliveira, Meg Doherty, Deenan Pillay, 2017, The Lancet. Infectious diseases.

Update of the drug resistance mutations in HIV-1: 2004.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2004, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Towards an ultra-rapid smartphone- connected test for infectious diseases

Eleni Nastouli, Jennifer C. Brookes, Hiromi Yatsuda, 2017, Scientific Reports.

Current Patterns in the Epidemiology of Primary HIV Drug Resistance in North America and Europe

Deenan Pillay, D. Pillay, 2004, Antiviral therapy.

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa

Andrew N. Phillips, Meg Doherty, John Stover, 2017, The Journal of infectious diseases.

Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns

Victor DeGruttola, Vincent Calvez, Maurizio Zazzi, 2004, Antiviral therapy.

Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type 1 Integrase

Deenan Pillay, D. Pillay, R. Myers, 2008, Journal of Virology.

2011 update of the drug resistance mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2011, Topics in antiviral medicine.

HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy

Stéphane Hué, Deenan Pillay, Patricia A Cane, 2004, AIDS.

Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo

Alan S. Perelson, Paul R. Grant, Deenan Pillay, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Role of Phylogenetics as a Tool to Predict the Spread of Resistance

Olivier Gascuel, Anna Zhukova, Deenan Pillay, 2017, The Journal of infectious diseases.

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

Hannah Green, David Dunn, Deenan Pillay, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach

Anne M Johnson, Martin Fisher, Deenan Pillay, 2010, AIDS.

Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults

Spiros Denaxas, Christina Pagel, Harry Hemingway, 2020, medRxiv.

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

Soo-Yon Rhee, Paul Sandstrom, Deenan Pillay, 2007, AIDS.